The Kenneth Norris Jr. comprehensive Cancer Center at the University of Southern California has been in existence since mid-1971 and continuously supported by a Cancer Center (Core) Support Grant since 1973. In the intervening years, the Center has developed to a major regional resource for cancer research, treatment, prevention and education. Center facilities have been built and developed with support from the NCI, the University, and, in its early days, the County of Los Angeles. Research is organized into six program areas, each headed by two senior investigators: Gene Regulation; Tumor Biology; lmmunobiology, Pathogenesis and Treatment; Developmental Therapeutics; Cancer Etiology; and Cancer Prevention Research and Education. In this application we are requesting the following: 1. partial salary support for the Center's senior leadership who are responsible for planning and overseeing our research efforts; 2. partial salary support for selected staff investigators who qualify according to NCI guidelines; 3. support for planning and evaluation to keep the Center at the forefront of cancer research; 4. support for the administrative infrastructure of the Center; 5. partial support for the Center's shared resources and the development of one new facility; 6. and support for developmental funds to help us recruit new investigators in the areas we have targeted for expansion. Continued funding from the Cancer Center (Core) Support Grant program will allow us build on and expand our strengths and to develop initiatives in promising areas of cancer research, treatment, prevention and education.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014089-16
Application #
3101375
Study Section
Special Emphasis Panel (SRC (V3))
Project Start
1980-04-01
Project End
1994-11-30
Budget Start
1991-01-10
Budget End
1991-11-30
Support Year
16
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Schirripa, Marta; Zhang, Wu; Yang, Dongyun et al. (2018) NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients. PLoS One 13:e0193640
McDonnell, Kevin J; Chemler, Joseph A; Bartels, Phillip L et al. (2018) A human MUTYH variant linking colonic polyposis to redox degradation of the [4Fe4S]2+ cluster. Nat Chem 10:873-880
Rhie, Suhn Kyong; Schreiner, Shannon; Farnham, Peggy J (2018) Defining Regulatory Elements in the Human Genome Using Nucleosome Occupancy and Methylome Sequencing (NOMe-Seq). Methods Mol Biol 1766:209-229
Ryser, Marc D; Min, Byung-Hoon; Siegmund, Kimberly D et al. (2018) Spatial mutation patterns as markers of early colorectal tumor cell mobility. Proc Natl Acad Sci U S A 115:5774-5779
Nguyen, Lisa; Wang, Zheng; Chowdhury, Adnan Y et al. (2018) Functional compensation between hematopoietic stem cell clones in vivo. EMBO Rep 19:
Zhou, Beiyun; Flodby, Per; Luo, Jiao et al. (2018) Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest 128:970-984
Tokunaga, Ryuma; Zhang, Wu; Naseem, Madiha et al. (2018) CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev 63:40-47
Jadvar, Hossein; Chen, Xiaoyuan; Cai, Weibo et al. (2018) Radiotheranostics in Cancer Diagnosis and Management. Radiology 286:388-400
McSkane, Michelle; Stintzing, Sebastian; Heinemann, Volker et al. (2018) Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study. Clin Colorectal Cancer 17:215-222.e3
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753

Showing the most recent 10 out of 842 publications